当前 T 细胞驱动的抗癌免疫治疗的局限性可通过一种原创的基于细胞外囊泡的疫苗策略克服
The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy.
32.0分
★☆☆☆☆
站内排序·非疗效
FRONTIER PAPERS
The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。